Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J WEGRZYN

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Leukemia & Lymphoma|September 14, 2004
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre studyM Kowal, A Dmoszyńska, K Lewandowski, et al.
The Journal of Biological Chemistry|January 15, 1992
Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor proteinR E Jones, D C Heimbrook, H E Huber, et al.
Molecular and Cellular Biology|August 1, 1988
Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alphaD Defeo-Jones, J Y Tai, R J Wegrzyn, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Leukemia & Lymphoma|September 14, 2004
Efficacy and safety of fludarabine and cyclophosphamide combined therapy in patients with refractory/recurrent B-cell chronic lymphocytic leukaemia (B-CLL)-Polish multicentre studyM Kowal, A Dmoszyńska, K Lewandowski, et al.
The Journal of Biological Chemistry|January 15, 1992
Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor proteinR E Jones, D C Heimbrook, H E Huber, et al.
Molecular and Cellular Biology|August 1, 1988
Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alphaD Defeo-Jones, J Y Tai, R J Wegrzyn, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D Knight, Nicholas D Adams, Joelle L Burgess, et al.
Pageof 4